Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timing of additional insulin aspart dosing for fat and protein in children with type 1 diabetes on multiple daily injections
2015-003666-85Phase 4Terminated
- Sponsor
- Oxford University Hospitals
- Start
- Jul 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of insulin aspart in diabetes mellitus type 1 (T1D) (3 arms), sponsored by Oxford University Hospitals. Started Jul 2017; status: terminated.
02
Drugs
insulin aspart
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2015-003666-85.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003666-85.